| Patents for C40B 30 - Methods of screening libraries (11,320) |
|---|
| 06/09/2011 | US20110136691 Gold-silver alloy nanoparticle chip, method of fabricating the same and method of detecting microorganisms using the same |
| 06/09/2011 | US20110136690 Methods for identifying and monitoring drug side effects |
| 06/09/2011 | US20110136689 Dual Expression Vector System for Antibody Expression in Bacterial and Mammalian Cells |
| 06/09/2011 | US20110136688 Recombinant bacteriophage and methods for their use |
| 06/09/2011 | US20110136687 METHOD FOR DETERMINING THE DEGREE OF METHYLATION OF DEFINED CYTOSINES IN GENOMIC DNA IN THE SEQUENCE CONTEXT OF 5'-CpG-3' |
| 06/09/2011 | US20110136686 Sequence matching allowing for errors |
| 06/09/2011 | US20110136685 Method for determining a predisposition to basal cell carcinoma and for screening treatments thereof |
| 06/09/2011 | US20110136684 Chemical reaction monitor |
| 06/09/2011 | US20110136683 Systems and Methods for Expression-Based Discrimination of Distinct Clinical Disease States in Prostate Cancer |
| 06/09/2011 | US20110136682 Antennary fucosylation in glycoproteins from cho cells |
| 06/09/2011 | US20110136681 Selection of stem cell clones with defined differentiation capabilities |
| 06/09/2011 | US20110136680 Tumor grading and cancer prognosis |
| 06/09/2011 | US20110136679 Imprinted Array |
| 06/09/2011 | US20110136678 Methodology for analysis of sequence variations within the hcv ns3/4a genomic region |
| 06/09/2011 | US20110136677 Methods of bead manipulation and forming bead arrays |
| 06/09/2011 | US20110136676 Geometric patterns and lipid bilayers for dna molecule organization and uses thereof |
| 06/09/2011 | US20110136675 Identification and characterization of proteins using new database search modes |
| 06/09/2011 | US20110135578 Mycobacterial infections |
| 06/09/2011 | DE112009001301T5 Mittel und Verfahren zur Beurteilung einer erhöhten Peroxisomenproliferation Means and methods for assessment of increased peroxisome proliferation |
| 06/09/2011 | CA2818133A1 Biological pathways associated with chemotherapy treatment in breast cancer |
| 06/09/2011 | CA2782465A1 Combined on-lattice/off-lattice optimization method for rigid body docking |
| 06/08/2011 | CN102089654A COPD biomarker signatures |
| 06/08/2011 | CN102089443A Method and apparatus for determining a probability of colorectal cancer in a subject |
| 06/08/2011 | CN102089249A Anti-biofouling materials and methods of making the same |
| 06/03/2011 | WO2011065982A2 Polymorphisms associated with parkinson's disease |
| 06/03/2011 | CA2782207A1 Polymorphisms associated with parkinson's disease |
| 06/03/2011 | CA2767028A1 Methods and compositions for detecting genetic material |
| 06/02/2011 | US20110130442 Nucleic acid capable of controlling degranulation of mast cell |
| 06/02/2011 | US20110130337 Polymorphisms associated with parkinson's disease |
| 06/02/2011 | US20110130303 In vitro diagnosis/prognosis method and kit for assessment of tolerance in liver transplantation |
| 06/02/2011 | US20110130302 Biological pathways associated with chemotherapy outcome for breast cancer |
| 06/02/2011 | US20110130301 Settings for recombinant adenoviral-based vaccines |
| 06/02/2011 | US20110130300 Assay for diagnosing streptococcus pneumoniae |
| 06/02/2011 | US20110130299 Plastidial microarray |
| 06/02/2011 | US20110130298 Method of predicting/optimizing hydrogen sulfide scavenging capacity and reduction of scale formation |
| 06/02/2011 | US20110130297 Quantum dot-sensory array for biological recognition |
| 06/02/2011 | US20110130296 Multi-gene classifiers and prognostic indicators for cancers |
| 06/02/2011 | US20110130295 Diagnostic Methods For Determining Prognosis Of Non-Small Cell Lung Cancer |
| 06/02/2011 | US20110129943 Method for Analyzing Proteins |
| 06/02/2011 | US20110129472 Methods for controlling vasculogenesis |
| 06/02/2011 | US20110129418 Brain Tumor Targeting Peptides and Methods |
| 05/31/2011 | US7951959 Hydrophilic labels for biomolecules |
| 05/31/2011 | CA2319080C Multivalent antibacterial agents |
| 05/27/2011 | CA2686584A1 Plasmodium proteases inhibitors and in silico screening methods for identifying the same |
| 05/26/2011 | WO2011063232A1 Biomarkers of cancer |
| 05/26/2011 | WO2011060557A1 Method for selection of aptamers |
| 05/26/2011 | WO2011060528A1 Heteropeptides useful for reducing nonspecific adsorption |
| 05/26/2011 | WO2007001928A3 Targets for inhibiting hcv replication |
| 05/26/2011 | WO2006127607A3 Pi3k pathway mutations in cancer |
| 05/26/2011 | US20110126300 High Through-Put Method of Screening Compounds for Pharmacological Activity |
| 05/26/2011 | US20110126299 Triple transgenic mouse model of autoimmune disease and nf-kappa b in vivo imaging |
| 05/26/2011 | US20110124713 Sam-ii riboswitch and uses thereof |
| 05/26/2011 | US20110124700 Systems and methods of cancer staging and treatment |
| 05/26/2011 | US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |
| 05/26/2011 | US20110124523 High Throughput Method for Detecting Apoptosis of Embryonic Stages of Metazoan Helminthic Parasites |
| 05/26/2011 | US20110124522 Methods of Disrupting Quorum Sensing to Affect Microbial Population Cell Density |
| 05/26/2011 | US20110124521 Use of MiR-26 Family as a Predictive Marker for Hepatocellular Carcinoma and Responsiveness to Therapy |
| 05/26/2011 | US20110124520 Compositions and Methods for Spatial Separation and Screening of Cells |
| 05/26/2011 | US20110124519 Method of assessing kidney function in a human subject |
| 05/26/2011 | US20110124518 Methods and compositions for the analysis of biological molecules |
| 05/26/2011 | US20110124517 Process for Determining the Genotype from a Biological Sample Containing Nucleic Acids of Different Individuals |
| 05/26/2011 | US20110124516 Polymer Particles and Uses Thereof |
| 05/26/2011 | US20110124515 Methods and Systems for Pre-Conceptual Prediction of Progeny Attributes |
| 05/26/2011 | US20110124514 Protein Signature Evaluation Platform |
| 05/26/2011 | US20110124513 Profiles of volatile hydrocarbons, markers of degradation/ageing of cellulosic material and markers of pathology |
| 05/26/2011 | US20110124512 METHODS AND KITS FOR SUSTAINING eNOS ACTIVITY TO INHIBIT PLATELET AGGREGATION, AND CLOT RETRACTION, AND PROMOTE FIBRINOLYSIS |
| 05/26/2011 | US20110124511 Gene Expression Profile-Facilitated In Vitro Fertilization |
| 05/26/2011 | US20110124510 Methods of labeling polynucleotide with dibenzorhodamine dyes |
| 05/26/2011 | US20110124509 Inhibition-Based High-Throughput Screen Strategy for Cell Clones |
| 05/26/2011 | US20110123558 Peptide with Reduced Dimer Formation |
| 05/26/2011 | US20110123530 Compositions and methods for treating and diagnosing asthma |
| 05/26/2011 | US20110123515 Egln2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart diseases |
| 05/26/2011 | CA2817671A1 Heteropeptides useful for reducing nonspecific adsorption |
| 05/26/2011 | CA2781408A1 Biomarkers of cancer |
| 05/26/2011 | CA2781019A1 Display of disulfide linked dimeric proteins on filamentous phage |
| 05/25/2011 | EP2325204A2 Production of motif-specific and context-independent antibodies using peptide libraries as antigens |
| 05/19/2011 | WO2011057411A1 Ovarian markers of oocyte competency and uses thereof |
| 05/19/2011 | WO2011017564A3 Identification and use of compounds for treating persistent pain |
| 05/19/2011 | US20110119776 Methods of diagnosing and prognosing lung cancer |
| 05/19/2011 | US20110118338 Methods, compositions and compound assays for inhibiting amyloid-beta protein production |
| 05/19/2011 | US20110118313 Identification of a molecular signature for antipsychotics and serms |
| 05/19/2011 | US20110118192 Methods and compositions for treating t-cell leukemia |
| 05/19/2011 | US20110118145 Copy number analysis of genetic locus |
| 05/19/2011 | US20110118144 Engineered phage vectors for the design and the generation of a human non-antibody peptide or protein phage library via fusion to pix of m13 phage |
| 05/19/2011 | US20110118143 Three dimensional tissues for high-throughput assays |
| 05/19/2011 | US20110118142 Dual labeling methods for measuring cellular proliferation |
| 05/19/2011 | US20110118141 Disease Specific Diagnostic Aid |
| 05/19/2011 | US20110118140 Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases |
| 05/19/2011 | US20110118139 Manipulation of Microparticles In Microfluidic Systems |
| 05/19/2011 | US20110118138 Solid phase multi-analyte assay |
| 05/19/2011 | US20110118137 Use of mass labeled probes to detect target nucleic acids using mass spectrometry |
| 05/19/2011 | US20110118136 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 05/19/2011 | US20110118135 Mutations in Contaction Associated Protein 2 (CNTNAP2) are Associated with Increased Risk for Ideopathic Autism |
| 05/19/2011 | US20110118134 Biomarkers for insulin sensitizer drug response |
| 05/19/2011 | US20110118133 Methods to identify patients at risk of developing adverse events during treatment with antidepressant medication |
| 05/19/2011 | US20110118132 Enzymatic Assays Using Umbelliferone Substrates with Cyclodextrins in Droplets of Oil |
| 05/19/2011 | US20110118131 Methods and materials for targeted mutagenesis |
| 05/19/2011 | US20110118130 Compositions and methods for defining cells |
| 05/19/2011 | US20110118129 Method for predicting therapy responsiveness in basal like tumors |
| 05/19/2011 | US20110118128 Biosensor device and method of manufacturing the same |